AGIO
AGIO
NASDAQ · Biotechnology

Agios Pharmaceuticals Inc

$33.54
+0.47 (+1.42%)
As of Sep 21, 2:01 PM ET ·
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Buy 12 75%
Hold 4 25%
Sell 0 0%
Price Target
Analyst Price Target -67.6% upside
Low Target $8.41
Average Target $10.87
High Target $14.57
Current Price $33.54
Current
$33.54
Target
$10.87
$8.41 $10.87 avg $14.57
Scenario Analysis
Bear Case
$8.41
-74.9%
Low target
Base Case
$10.87
-67.6%
Avg target
Bull Case
$14.57
+-56.6%
High target
Risk/Reward
0.8x
Unfavorable
Price in Context
52-Week High
$46.00
-27.1% from high
52-Week Low
$22.24
+50.8% from low
Target vs 52W High
$10.87
-76.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.9%
AMGN
Amgen Inc
Hold 43 47% $190.87 -53.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.6%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -14.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
Hold 30 37% $149.45 -18.1%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -63.4%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -40.8%